The ACMD is accepting written submissions of evidence until 30 June on two topics:
- Young people’s drug use
- Naloxone provision
On young people’s drug use, the ACMD is interested to hear about:
- prevalence and nature of drug use among young people
- evidence of effective treatment
- descriptions of interventions or treatment models being used
- how responses could be improved
- case studies of note
On naloxone provision, the ACMD is interested to hear about:
- prevalence and nature of naloxone provision, carriage and use
- evidence of effectiveness of naloxone provision in different settings
- evidence of who is administering naloxone (police, voluntary services, etc.)
- barriers to uptake of naloxone (both intramuscular and intranasal naloxone)
- evidence of collaborative approaches to provision
- case studies of note
We encourage individuals and organisations across the drug and alcohol field to make submissions to the ACMD’s work – forms are available on the ACMD website.
Collective Voice will be submitting evidence to both workstreams and we are inviting stakeholders to feed in information as part of our submission. We have set up Slack channels for both topics on the ‘Making a Difference Together’ Slack group and we welcome people’s input on that channel.
Alternatively, you can email CV’s Campaigns Officer, Peter Keeling [email protected].
It’s important that our submission is informed by the expertise of people working on these issues at the frontline, as well as people with lived experience, so please do get in touch if you have evidence on the above topics that we can include.
Related Content
Collective Voice responds to the latest estimates of how many people use drugs
This week has seen the publication of a new Government youth strategy and a national plan to end homelessness. We need to see the same
Collective Voice responds to the latest statistics on treatment for alcohol and other drug issues
Today’s statistics show the progress and return on investment that charities have delivered. But these gains are now at risk, because the Government has abandoned
Ketamine: Current challenges, successes and next steps for treatment
The meeting showed the importance of bringing people together to share successes, as well as challenges faced, and to discuss potential ways forward. Video of